COVID-19: BioNTech-Pfizer vaccine to begin trials on children, infants
Published
The BioNTech-Pfizer coronavirus vaccine is now being tested on young children under-12, with efficacy data expected later this year. The vaccine makers hope the shot can be administered to kids by 2022.
Full Article